AUG 14, 2026 · JOURNAL ARTICLE
Lactate dehydrogenase-to-lymphocyte ratio predicts overall and progression-free survival among patients with advanced small-cell lung cancer receiving first-line chemoimmunotherapy
Medicine
A real result from a sound but limited retrospective study showing LLR predicts OS and PFS in advanced SCLC, but small sample size, single disease context, and lack of prospective validation limit immediate clinical application.
Reported
Sample size64
High LLR prevalence10/64 (16%)
LLR cutoff value>471.5